Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Treat Liver Cancer

Carlos Dujovne, MD, Professor of Medicine and Director
Carlos Dujovne, MD, Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study (www.astrazeneca.com)
1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000...
Carlos Dujovne, MD, Professor of Medicine and Director
Carlos Dujovne, MD, Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: Many Trial Reports on FDA-Approved Drugs Go Unpublished (www.washingtonpost.com)
This article is not news for clinical researchers like myself that have performed hundreds of clinical trials in collaboration with the Pharmaceutical Industry. Some of the most common reasons for that are: A)Negative studies are difficult to get published.B)Negative results for the dug of the...
Carlos Dujovne, MD, Professor of Medicine and Director
Carlos Dujovne, MD, Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 (newsroom.lilly.com)
More than 50% of patients have the 3 ccomponents to qualify for diagnosis of Metabolic Syndrome.Twwo of the components,Diabetes and Obesity are present in 20-25% of them and are difficult to control.Exenatide seems to provide that benefit.
Analysis of: Magnetic device as the drug (www.medicicom.com)
Madu strip is a magnetic medical device created by inventor who has also invented and patented a magnetic trap, medical device which is utilised for non-invasive extraction of foreign ferrous bodies which enter human body as the result of trauma. Magnetic trap proved its value in this respect,...
Analysis of: Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers (www.pipelinereview.com)
The use of immunoconjugates in the development of monoclonal antibodies has been long tested with toxins but not with pro-drugs
Analysis of: Vermillion Announces Positive Results From Clinical Trial of Ovarian Tumor Triage Test; Study Meets Primary Endpoints (www.pipelinereview.com)
Early detection of ovarian cancer is of paramount importance
Analysis of: MediGene Achieves Excellent Efficacy Data of EndoTAG (TM) 1 in Clinical Phase II Trial in Pancreatic Carcinoma (www.pipelinereview.com)
All major clinical trials in  patients with pancreatic cancer have generated questionable actual benefit
Analysis of: Piramed Announces Progress in its Collaboration with Genentech, Inc. (DNA) to Develop a New Class of Anti-cancer Drugs (www.pipelinereview.com)
The high cost of all the new agents is a major problem, especially in developing countries
Analysis of: Researchers Find Cause of Severe Allergic Reaction to Cancer Drug (pharmalive.com)
The role of immune system remains important and shouhd never neglected even with all these new molecules
Analysis of: Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer (jco.ascopubs.org)
Vaccines have always been a hope but until now no significant results have been recorded in solid tumors

Page : 1 2 3 4 5 6 7 Next1 to 10 of 70

Analytics


Generated at 2009-01-07T19:00:58.307